PubRank

H G Sahl

Author PubWeight™ 87.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 1999 5.30
2 Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob Agents Chemother 1985 3.83
3 Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 2000 3.65
4 Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol 1998 2.69
5 Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis. J Gen Microbiol 1981 2.20
6 Mode of action of the staphylococcinlike peptide Pep 5: voltage-dependent depolarization of bacterial and artificial membranes. J Bacteriol 1988 2.10
7 Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry 1995 2.10
8 The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother 1998 2.06
9 Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes. FEBS Lett 1989 1.95
10 Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis 1999 1.87
11 Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol 1989 1.85
12 Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol 1987 1.82
13 Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes. Arch Microbiol 1985 1.81
14 Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun 1996 1.79
15 Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol Microbiol 1996 1.71
16 Influence of the staphylococcinlike peptide Pep 5 on membrane potential of bacterial cells and cytoplasmic membrane vesicles. J Bacteriol 1985 1.71
17 The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur J Biochem 1997 1.59
18 Mode of action of the staphylococcin-like peptide Pep 5 and culture conditions effecting its activity. Zentralbl Bakteriol Mikrobiol Hyg A 1982 1.58
19 The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes. Eur J Biochem 1989 1.54
20 Protein engineering of lantibiotics. Antonie Van Leeuwenhoek 1996 1.54
21 Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob Agents Chemother 1995 1.52
22 Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. Eur J Biochem 1995 1.50
23 Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin. Antimicrob Agents Chemother 1985 1.48
24 Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem 1990 1.40
25 Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol 1998 1.29
26 Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem 1999 1.29
27 Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol 1998 1.28
28 Posttranslationally modified bacteriocins--the lantibiotics. Biopolymers 2000 1.27
29 Immunity to lantibiotics. Antonie Van Leeuwenhoek 1996 1.24
30 Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl Environ Microbiol 1996 1.18
31 Construction of an expression system for engineering of the lantibiotic Pep5. Appl Environ Microbiol 1994 1.16
32 Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol Lett 1995 1.15
33 Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin. J Bacteriol 1992 1.14
34 Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepI and localization and functional analysis of its gene product. Appl Environ Microbiol 1994 1.14
35 Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22. Eur J Biochem 1994 1.14
36 Interaction of the staphylococcin-like peptide Pep 5 with cell walls and isolated cell wall components of Gram-positive bacteria. Zentralbl Bakteriol Mikrobiol Hyg A 1985 1.10
37 Plasmid involvement in production of and immunity to the staphylococcin-like peptide Pep 5. J Gen Microbiol 1984 1.07
38 Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria. Zentralbl Bakteriol 1993 1.05
39 Identification and analysis of a gene encoding a Fur-like protein of Staphylococcus epidermidis. FEMS Microbiol Lett 1996 1.03
40 New insights into the mechanism of action of lantibiotics--diverse biological effects by binding to the same molecular target. J Antimicrob Chemother 2000 1.02
41 Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. Eur J Biochem 1995 1.02
42 Molecular analysis of expression of the lantibiotic pep5 immunity phenotype. Appl Environ Microbiol 1999 1.02
43 The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7. Antonie Van Leeuwenhoek 1996 1.00
44 The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur J Biochem 1994 0.96
45 Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect Immun 1999 0.95
46 Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate. FEMS Microbiol Lett 1992 0.91
47 Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Eur J Biochem 1995 0.90
48 Mechanism of action and limited cross-resistance of new lipopeptide MX-2401. Antimicrob Agents Chemother 2011 0.90
49 Molecular characterisation of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus. J Mol Biol 2001 0.89
50 Purification and partial characterization of a murein hydrolase, millericin B, produced by Streptococcus milleri NMSCC 061. Appl Environ Microbiol 2000 0.88
51 Effects of the lantibiotic mersacidin on the morphology of staphylococci. Zentralbl Bakteriol 1996 0.87
52 Malic enzyme of chromatium vinosum. Arch Microbiol 1980 0.86
53 GIS-supported investigation of a nosocomial Salmonella outbreak. Int J Hyg Environ Health 2000 0.85
54 The genetics of lantibiotic biosynthesis. Bioessays 1995 0.85
55 Effect of leader peptide mutations on biosynthesis of the lantibiotic Pep5. FEMS Microbiol Lett 1997 0.84
56 Isolation and mode of action of a staphylococcin-like substance active against gram-positive and gram-negative bacteria. J Gen Microbiol 1984 0.82
57 Unique peptide modifications involved in the biosynthesis of lantibiotics. Trends Biotechnol 1995 0.82
58 Carnocin UI49, a potential biopreservative produced by Carnobacterium piscicola: large scale purification and activity against various gram-positive bacteria including Listeria sp. Int J Food Microbiol 1993 0.82
59 Purification and properties of LIQ 4, an antibacterial substance produced by Streptococcus faecalis var. liquefaciens K4. J Gen Microbiol 1985 0.81
60 Influence of cationic peptides on the activity of the autolytic endo-beta-N-acetylglucosaminidase of Staphylococcus simulans 22. FEMS Microbiol Lett 1989 0.81
61 Isolation of a new epidermin variant from two strains of Staphylococcus epidermidis--frequency of lantibiotic production in coagulase-negative staphylococci. Zentralbl Bakteriol 1996 0.78
62 Antibacterial activities of Candida yeasts. Partial purification and characterization of the active substance of Candida guilliermondii. Zentralbl Bakteriol Mikrobiol Hyg A 1982 0.77
63 Lytic activities, protein profiles and morphologic characteristics of new bacteriophages isolated from canine and human Staphylococcus aureus strains. Zentralbl Veterinarmed B 1992 0.75
64 [Infantile Campylobacter enteritis (author's transl)]. Klin Padiatr 1981 0.75
65 [Extent of bacterial contamination is a derminant fur microvascular damage in soft tissue infection]. Langenbecks Arch Chir Suppl Kongressbd 1998 0.75